All T cell populations, including γδ T cell subsets, demonstrated an increased proportion of CD69+ cells in CSF (an average of 15–30% in the different cell populations) compared to PBMC (average of 7% or less) from new-MS patients, indicating a memory/tissue resident T cell phenotype (Figures 2A,B). The gene discussed is CD69; the disease is myeloid sarcoma.